Viewing nowWinrica Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

MFDS item code 201800768 · Approved 2018.02.09 · Insurance code 651602340
Treatment of neuropathic pain and fibromyalgia, and adjunctive treatment of partial seizures in epilepsy
This medication is used for the treatment of pain from peripheral and central neuropathy in adults. Additionally, it is administered as an adjunctive treatment for patients with epilepsy experiencing partial seizures, whether accompanied by secondary generalized symptoms or not. It also helps alleviate pain in patients with fibromyalgia. It is effective in treating a variety of neuro-related symptoms.
This drug is administered orally, regardless of food, in 2 divided doses of the total daily dose of pregabalin. Since this drug is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with Renal Impairment’.) 1. Neuropathic Pain 1) Peripheral Neuropathic Pain Adults: This drug may be administered at an initial dose of 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, the dose may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central Neuropathic Pain Adults: This drug may be administered at an initial dose of 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of Treatment’.) 2. Epilepsy Adults: This drug may be administered at an initial dose of 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, the dose may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this drug for fibromyalgia is 300 mg to 450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased to 150 mg twice daily (300 mg/day) within 1 week. For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased to 225 mg twice daily (450 mg/day) within 1 week. Clinical studies were also conducted at a dose of 600 mg/day, but there is no evidence of additional benefit or adequate tolerability at this dose. Given the dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of Treatment Based on current clinical experience, if treatment with this drug is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with Renal Impairment After entering the systemic circulation, this drug is excreted primarily by the kidneys in unchanged form. Since the clearance of this drug is directly affected by creatinine clearance, dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. This drug is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) ≥60: Starting dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥30 -<60: Starting dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥15 -<30: Starting dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID Creatinine clearance (CLcr), (mL/min) <15: Starting dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: 25, 100, single dose b TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified under the method of administration. b: The supplemental dose refers to a dose administered once as an additional dose. 6. Patients with Hepatic Impairment Dose adjustment is not required in patients with hepatic impairment. 8. Elderly Patients (65 years of age or older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Use is not recommended because there are insufficient data on safety and efficacy. Adolescent patients aged 12 to 17 years: Use is not recommended because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts or behavior; therefore, any changes in mood or symptoms of depression during treatment should be reported to medical personnel immediately. Patients with hypersensitivity to this medication should not take it. Patients with diabetes should carefully manage blood sugar levels, as this medication may lead to weight gain and make it difficult to control blood sugar. If symptoms such as swelling around the face or neck and difficulty breathing occur, the medication should be discontinued immediately, and the patient should visit a hospital. Elderly patients may experience increased dizziness or drowsiness from this medication, so caution is advised after taking it, and care should be taken to reduce the risk of falls. If vision becomes blurry or abnormal eye symptoms occur, the medication should be stopped, and a doctor should be consulted. Abruptly discontinuing this medication can cause withdrawal symptoms such as insomnia, headache, and anxiety, so it should be reduced gradually under medical supervision. There is a risk of drug abuse, so patients with a history of mental illness or substance abuse should consult healthcare professionals before taking this medication. Patients with impaired kidney function may require dose adjustments for this medication. Patients with heart conditions should be cautious as this medication may worsen symptoms of congestive heart failure. Care should be taken when this medication is used in combination with other central nervous system depressants or opioid analgesics, as there is an increased risk of respiratory depression. During early pregnancy, there is a risk of fetal malformation; thus, pregnant women should avoid taking this medication, and women of childbearing age should use effective contraceptive methods. Lactating women should carefully consider whether to breastfeed while taking this medication, as it can be transmitted through breast milk and may affect the baby. It is advisable to avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness from this medication has resolved. In case of overdose, symptoms such as mental confusion, severe drowsiness, or seizures may occur; immediate medical attention is required, and treatment such as hemodialysis may be necessary. This medication should be kept out of reach of children and should not be transferred to another container for safety.
Suicidal thoughts, suicidal behavior, depression, abnormal mood and behavioral changes, angioedema, facial swelling, periorbital swelling, upper airway swelling, dizziness, drowsiness, loss of consciousness, confusion, mental disorder, blurred vision, vision changes, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, sadness, thoughts of suicide, pain, seizures, hyperhidrosis, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, reduced respiratory function, vomiting, abdominal distension, constipation, dry mouth, bloating, hypersalivation, gastroesophageal reflux disease, oral sensory reduction, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweats, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasms, pain in the neck, muscle rigidity, rhabdomyolysis, urinary disturbances, urinary incontinence, reduced urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, nipple discharge, breast enlargement, peripheral edema, edema, gait abnormalities, falling, a feeling of drunkenness, altered sensation, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased serum creatine phosphokinase, increased aspartate aminotransferase, increased blood sugar, decreased platelet count, decreased potassium levels in the blood, weight loss, increased serum creatinine, decreased white blood cell count, nasopharyngitis, neutropenia, increased appetite, appetite suppression, hypoglycemia, confusion, disorientation, irritability, feeling good, decreased libido, depersonalization, sexual hyperesthesia, anxiety, mood swings, emotional low, emotional highs, difficulty finding the right terms, hallucinations, abnormal dreams, increased libido, panic attacks, loss of control, apathy, ataxia, motor coordination abnormalities, balance disorders, amnesia, attention deficit, memory impairment, tremors, dysarthria, sensory disturbances, sensory reduction, sedation, hypersomnia, cognitive impairment, nystagmus, language disorders, myoclonic jerks, reduced reflexes, movement abnormalities, psychomotor agitation, positional dizziness, hypersensitivity, burning sensation, activity tremor, syncope, confusion, hypokinesia, olfactory disturbances, taste loss, writing disability, diplopia, dry eyes, conjunctival swelling, vision loss, eye pain, eye fatigue, increased tear production, ocular irritation, mydriasis, tremors during motion, changes in the depth perception of vision, strabismus, brightness of vision, vertigo, auditory hyperesthesia, first-degree heart block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tension, nasal dryness, respiratory depression, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis (facial paralysis), affective disorder, drowsiness, confusion state, agitation, restlessness, exacerbation of seizures, sleep disturbances, bloody stool, tinnitus, gastrointestinal disturbances, ataxia, verbal communication disorders, memory impairment, attention deficit, fatigue, weakness, gait abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it is important to store it in a cool place at a temperature between 15 and 30 degrees Celsius to maintain its efficacy.
A hard capsule with a reddish-brown upper part and a white lower part containing white powder.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.